Novo Nordisk Aktie
WKN DE: A3EU6F / ISIN: DK0062498333
|
30.09.2025 00:05:44
|
Why Novo Nordisk Stock Slumped on Monday
Drug tariffs, tough competition, and a fresh analyst recommendation downgrade were the burdens pulling down Novo Nordisk (NYSE: NVO) stock on Monday. In some respects, then, it was surprising that the company's shares didn't do worse than the 0.2% slump they were hit with across that trading session. Meanwhile, the S&P 500 (SNPINDEX: ^GSPC) ended the day positively, rising by 0.3%.Monday's downgrading entity was white-shoe investment bank Morgan Stanley, whose analyst Thibault Boutherin felt compelled to rerate Novo Nordisk as an underweight (sell, in other words). Previously, the pundit had tagged it as equal weight (hold). Image source: Getty Images.Continue readingWeiter zum vollständigen Artikel bei MotleyFool
Der finanzen.at Ratgeber für Aktien!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Novo Nordiskmehr Nachrichten
Analysen zu Novo Nordiskmehr Analysen
| 14.11.25 | Novo Nordisk Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 11.11.25 | Novo Nordisk Neutral | UBS AG | |
| 11.11.25 | Novo Nordisk Buy | Deutsche Bank AG | |
| 10.11.25 | Novo Nordisk Halten | DZ BANK | |
| 10.11.25 | Novo Nordisk Neutral | UBS AG |
Aktien in diesem Artikel
| Novo Nordisk | 41,69 | 0,18% |
|
| Novo Nordisk (spons. ADRs) | 41,70 | 0,85% |
|